Psychopharmacology

, Volume 199, Issue 1, pp 133–134

Authors’ reply

Letter to the Editors
  • 29 Downloads

References

  1. Barbui C, Cipriani A, Brambilla P, Hotopf M (2004) “Wish bias” in antidepressant drug trials? J Clin Psychopharmacol 24:126–130PubMedCrossRefGoogle Scholar
  2. Ioannidis JPA (2005) Why most published research findings are false. PLoS Medicine 2:0696–0701Google Scholar
  3. Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME (2008) Comprehensive Analysis of Remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry 63:424–434PubMedCrossRefGoogle Scholar
  4. Smith D, Dempster C, Glanville J et al (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 180:396–404PubMedCrossRefGoogle Scholar
  5. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252–360PubMedCrossRefGoogle Scholar
  6. Weinmann S, Becker T, Koesters M (2008) Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis. Psychomarmacology 196:511–520CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Stefan Weinmann
    • 1
    • 2
  • Markus Koesters
    • 1
  • Thomas Becker
    • 1
  1. 1.Department of Psychiatry II, University of UlmGünzburgGermany
  2. 2.Charité, Social Medicine, Epidemiology and Health EconomicsUniversity Medicine BerlinBerlinGermany

Personalised recommendations